Medivis Company Profile

Background

Founded in 2016 and headquartered in New York City, Medivis is a medical technology company dedicated to revolutionizing surgical procedures through the integration of augmented reality (AR) and artificial intelligence (AI). The company's mission is to enhance surgical precision and improve patient outcomes by providing surgeons with advanced visualization tools that overlay critical imaging data directly onto the operative field. Medivis's innovative approach positions it as a leader in the medical technology sector, aiming to set new standards in surgical navigation and medical imaging.

Key Strategic Focus

Medivis focuses on developing AR and AI-driven platforms that transform surgical visualization and navigation. Its core objectives include creating intuitive, user-friendly systems that integrate seamlessly into existing surgical workflows, thereby enhancing the surgeon's experience and improving patient care. The company's primary markets encompass neurosurgery, orthopedic surgery, and other specialties where precise imaging and navigation are critical.

Financials and Funding

Since its inception, Medivis has successfully secured significant funding to support its growth and innovation initiatives. In June 2023, the company announced a $20 million Series A funding round led by Thrive Capital, with participation from Initialized Capital, Mayo Clinic, and notable individual investors such as Bob Iger and Kevin Durant. This funding is intended to accelerate the development and commercialization of Medivis's AR surgical solutions, expand its market presence, and enhance research and development efforts.

Pipeline Development

Medivis has developed a suite of products designed to enhance surgical precision and patient outcomes:

• SurgicalAR®: An FDA-approved AR platform that overlays 3D images onto patients for precise procedure planning in fields like neurosurgery, orthopedics, and reconstructive surgery. It processes patient-specific MRI and CT data in under 10 seconds, visualizing internal anatomy for applications such as oncology and trauma. Operable on Microsoft’s HoloLens 2, it uses hand gestures for interactive tools like cutting planes, cropping, and brush tools.

• AnatomyX®: An AR software for education, compatible with HoloLens 2 and Magic Leap headsets, featuring over 5,000 in-house designed 3D anatomy models. Key features include multi-user AR experiences, detailed anatomy data, and a custom portal for classroom management, quizzes, and progress tracking. Students using AnatomyX reported a 1–2 letter grade improvement, with 95% acknowledging enhanced learning.

• Spine Navigation: In April 2025, Medivis received FDA 510(k) clearance for its Spine Navigation platform, marking a significant advancement in surgical technology. This platform utilizes AR and AI to empower surgeons with holographic navigation across open and minimally invasive spine procedures. The commercial launch of Spine Navigation is set to make it available to hospitals and ambulatory surgical centers nationwide.

These products are at various stages of development and commercialization, with ongoing efforts to expand their applications and integrate additional features based on user feedback and technological advancements.

Technological Platform and Innovation

Medivis's technological platforms are distinguished by their integration of proprietary computer vision algorithms, AI segmentation, real-time data analysis, and advanced image processing. These innovations deliver precise, context-aware insights throughout the surgical workflow. The company's AR solutions are designed for ergonomic freedom, utilizing lightweight hardware that allows surgeons to visualize critical information comfortably while operating. Hand tracking and voice commands grant complete control of the environment, eliminating attention shifts away from the operative field. Additionally, Medivis's platforms offer seamless integration with existing surgical hardware and imaging systems, ensuring minimal disruption to established workflows.

Leadership Team

Medivis's leadership team comprises experienced professionals with diverse backgrounds in medicine, technology, and business:

• Dr. Osamah Choudhry: Co-Founder and Chief Executive Officer. Dr. Choudhry brings extensive experience in neurosurgery and a passion for integrating technology into medical practice.

• Dr. Christopher Morley: Co-Founder, President, and Chief Operating Officer. Dr. Morley has a background in radiology and is dedicated to enhancing medical imaging through innovative technologies.

• Amy Lynn: Chief Compliance Officer. Amy oversees regulatory compliance and ensures that Medivis's products meet the highest standards of safety and efficacy.

• Steven Kuyan: Advisor. Steven provides strategic guidance, leveraging his expertise in technology commercialization and startup growth.

Competitor Profile

Market Insights and Dynamics: The global medical technology market is highly competitive, with rapid advancements in AR and AI applications for surgical procedures. The demand for innovative surgical solutions is growing, driven by the need for enhanced precision, reduced surgical errors, and improved patient outcomes.

Competitor Analysis: Medivis faces competition from several companies in the medical imaging and surgical navigation space:

• Novarad: Founded in 1988 and based in Provo, Utah, Novarad offers medical imaging solutions and competes in the health care technology sector.

• Subtle Medical: Established in 2017 and headquartered in California, Subtle Medical focuses on AI-powered medical imaging enhancement, operating within the same health care technology space as Medivis.

• Imbio: A medical imaging company specializing in AI-driven analysis and visualization, providing solutions that overlap with Medivis's offerings.

• Vena Medical: Develops viewing surgical solutions, contributing to the competitive landscape in surgical visualization technologies.

These competitors have established market presence and offer various technologies that challenge Medivis's position in the industry.

Strategic Collaborations and Partnerships

Medivis has established significant collaborations to enhance its market position and innovation capacity:

• Veterans Health Administration (VHA): In February 2020, Medivis partnered with the VHA, Verizon, and Microsoft to deliver the VA’s first 5G-enabled clinical care system at the VA Palo Alto healthcare.